Stocks Screeners Features Pricing
Sign In Get Started

McKesson Corporation Stock Analysis

NYSE: MCK | Health Care | Health Care Distributors
Price $827.14 $29.05 (-3.39%)
P/E Ratio 22.6 TTM
52-Week Range
Low $637 High $999
Market Cap $102.65B USD
ROE Negative equity

Market data as of Aug 3, 2026 · Financials as of Mar 2026

Published Jun 17, 2026 · Updated Jun 18, 2026

McKesson Corporation (MCK) has put up some notable numbers lately. Here is a data-driven look at its financials, valuation, and shareholder returns.

McKesson Corporation's Revenue Performance

McKesson Corporation posted revenue of $403.43B in FY2026, a 12.4% rise from $359.05B in FY2025.

Over 10 years, McKesson Corporation's revenue has compounded at 7.8% annually. That is not a breakout compounder, but it is steady enough to signal a durable underlying business.

A $403.43B revenue base firmly places McKesson Corporation in the large-cap tier among US health care companies.

Ten consecutive years of revenue moving in the same direction is a signal worth taking seriously. That kind of consistency points to structural demand, not a cyclical tailwind.

Revenue Trend
Year Revenue YoY %
FY2026 $403.43B +12.4%
FY2025 $359.05B +16.2%
FY2024 $308.95B +11.7%
FY2023 $276.71B +4.8%
FY2022 $263.97B +10.8%

View the detailed revenue trend and growth analysis

McKesson Corporation's Revenue Breakdown

Breaking down McKesson Corporation's revenue mix in FY2025 clarifies where the business actually generates its sales.

McKesson Corporation Business Segment Performance (FY2025)

U.S. Pharmaceutical Segment91.3% · $327.72B
International Segment4.1% · $14.72B
Medical-Surgical Solutions Segment3.2% · $11.39B
Prescription Technology Solutions1.5% · $5.22B
SegmentRevenue% of Total
U.S. Pharmaceutical Segment$327.72B91.3%
International Segment$14.72B4.1%
Medical-Surgical Solutions Segment$11.39B3.2%
Prescription Technology Solutions$5.22B1.5%

The dominant revenue source is U.S. Pharmaceutical Segment, which accounts for 91.3% of revenue and expanded 17.6% over the prior year.

Geographically, McKesson Corporation's sales are divided between United States (83%) and International (17%).

Profitability

Profitability improved meaningfully, with net income reaching $4.76B in FY2026, a 44.5% jump from FY2025.

Net profit margin came in at 1.2% in FY2026, roughly in line with prior periods.

Diluted earnings per share landed at $38.38 in FY2026, compared to $25.72 a year earlier.

Explore the profitability trend in detail below

Dividends & Buybacks

McKesson Corporation's FY2026 dividend was $3.07 per share, translating to a yield of 0.39%.

The dividend track record carries some weight: McKesson Corporation has sustained payouts for 10+ consecutive years.

A payout ratio of 8.0% leaves the company plenty of room to grow the dividend while keeping earnings available for reinvestment.

Dividend Per Share & Payout Ratio
Year DPS Payout Ratio
FY2026 $3.07 8.0%
FY2025 $2.69 10.5%
FY2024 $2.34 10.5%
FY2023 $2.05 8.2%
FY2022 $1.80 24.9%

Over 11 years, McKesson Corporation has returned $28.02B to shareholders through stock buybacks.

Explore McKesson Corporation's capital return activity in the charts below

McKesson Corporation Debt & Liquidity

Financial Position Summary (FY2026)
Metric Value
Cash & Short-term Investments $3.98B
Total Debt $6.37B
Shareholders' Equity -$2.17B
Total Assets $82.32B
Debt-to-Equity Ratio N/A (negative equity)
Current Ratio 0.85x
Interest Coverage 26.1x
Free Cash Flow (TTM) $5.72B

McKesson Corporation carries negative shareholder equity (equity deficit), a current ratio of 0.85, and interest coverage of 26.1x in FY2026. Taken together, these figures suggest adequate financial health with manageable leverage.

McKesson Corporation's shareholders' equity sits at negative $2.17B. That figure sounds alarming in isolation, but it is characteristic of businesses that aggressively return capital through buybacks, funded by consistent operating cash flows.

A current ratio of 0.85x signals a limited near-term liquidity cushion for McKesson Corporation.

With interest coverage at 26.1x, McKesson Corporation has substantial headroom above its debt obligations.

Free cash flow of $5.72B underscores the company's capacity to self-fund growth and continue returning capital to shareholders.

Dive into McKesson Corporation's balance sheet strength below

As of FY2026, McKesson Corporation employed 43,000 people, generating roughly $9.4M in revenue per employee.

Explore McKesson Corporation's headcount trend and workforce productivity

Is McKesson Corporation Overvalued?

Putting a fair value on McKesson Corporation requires running the numbers through multiple valuation lenses.

McKesson Corporation shares are currently trading at $827.14.

Applying the P/E Ratio model produces a fair value of $1,134 for McKesson Corporation.

Intrinsic value estimates using the DCF and EPS Growth models are also available. Sign up to see the full breakdown with fair value estimates.

Valuation Models
Model Est. Fair Value vs. Current Price
P/E Ratio $1,134 27.1% upside to fair value
DCF Upgrade Upgrade
EPS Growth Upgrade Upgrade

What Stands Out

Pulling it all together, here is what McKesson Corporation's (MCK) latest numbers actually tell investors.

FY2026 revenue came in at $403.43B, up 12.4% year-over-year.

Over a 10-year horizon, revenue has compounded at 7.8% annually.

The business is profitable, generating a net margin of 1.2% and net income of $4.76B.

McKesson Corporation returned $5.13B to shareholders in FY2026 through dividends and/or buybacks.

Shareholders' equity is negative, which in this case reflects an aggressive buyback program in a company with strong underlying cash flows.

The P/E Ratio model implies 27.1% upside to fair value. The remaining 2 models are worth cross-checking before drawing a conclusion. Sign up to see the full analysis.

The charts and valuation models further down the page offer a closer look at McKesson Corporation's financial trajectory.

Frequently Asked Questions

What was McKesson Corporation's revenue in FY2026?
McKesson Corporation (MCK) posted total revenue of $403.43B in FY2026.
Is McKesson Corporation profitable?
McKesson Corporation reported net income of $4.76B in FY2026, with a net margin of 1.2%.
Does McKesson Corporation pay a dividend?
Yes, McKesson Corporation pays a regular dividend to shareholders.
Is McKesson Corporation (MCK) undervalued right now?
Based on the P/E ratio model, McKesson Corporation appears undervalued, trading at a 32% discount to its estimated fair value of $1,140.
What industry is McKesson Corporation in?
McKesson Corporation is in the Health Care Distributors industry within the Health Care sector.

What does McKesson Corporation do?

McKesson distributes pharmaceuticals, medical-surgical supplies, and specialty medications to pharmacies, hospitals, and healthcare providers across the U.S. and 13 European countries plus Canada. Key segments include U.S. Pharmaceutical, Medical-Surgical Solutions, Prescription Technology Solutions (RxTS), and International, with RxTS connecting biopharma, providers, and payers to improve medication access and adherence.

Detailed Charts

McKesson Corporation Performance

5-year trend showing revenue, gross profit, and net profit

FY2022 – FY2026

McKesson Corporation's revenue grew 12.4% to $403.43B and net profit grew 44.5% to $4.76B YoY in FY2026, indicating healthy business momentum.

Understanding Company Performance

Revenue is McKesson Corporation's total income from operations. Gross Profit is revenue minus cost of goods sold — the higher it is relative to revenue, the stronger the company's pricing power. Net Profit is the bottom line after all expenses, taxes, and interest. Consistent growth across all three signals a healthy, expanding business. Compare with peers in the same sector.

Is McKesson Corporation Profitable?

5-year trend showing gross, operating, and net profit margins

FY2022 – FY2026

McKesson Corporation's net profit margin of 1.2% in FY2026 reflects weak profitability, with operating margin at 1.6% and gross margin at 3.6%.

Understanding Profitability Margins

Gross Profit Margin (GPM) shows what percentage of McKesson Corporation's revenue remains after direct production costs. Operating Profit Margin (OPM) factors in operating expenses like R&D and SG&A. Net Profit Margin (NPM) is the final profitability after all costs including interest and taxes. Stable or improving margins indicate pricing power and cost discipline.

McKesson Corporation Revenue & Earnings Growth

5-year trend showing revenue and diluted EPS

FY2022 – FY2026

McKesson Corporation's revenue grew 12.4% YoY in FY2026, with EPS growing 49.2%, solid growth across both metrics.

Understanding Revenue & Earnings Growth

Revenue is McKesson Corporation's total income from operations — the top line. Diluted EPS (Earnings Per Share) is net income divided by all shares that could exist if stock options, RSUs, and convertibles were exercised. Revenue shows how fast the business is growing; EPS shows how much of that growth reaches shareholders after all costs and dilution. Healthy companies tend to grow both in tandem; when revenue grows but EPS shrinks, margins are compressing. Use our stock screener to compare growth profiles across companies.

McKesson Corporation Compound Annual Growth Rate (CAGR)

Metric 1-Year 5-Year 10-Year
Revenue +12.4% +11.1% +7.8%
Net Income +44.5% N/A +7.7%
EPS +49.2% N/A +14.7%
Share Price +18.7% +32.7% +16.4%

McKesson Corporation's 10-year revenue CAGR of 7.8% reflects moderate long-term growth, with EPS CAGR of 14.7% outpacing revenue, indicating improving profitability. The share price has compounded at 16.4% annually over a comparable period, broadly tracking fundamentals.

McKesson Corporation Quarterly Performance

Quarterly revenue and net income with a weekly share-price overlay

Upgrade to see the full 5 years (20 quarters) of quarterly data.

FY2026

How to Read Quarterly Performance

Quarterly revenue and net income are McKesson Corporation's most recent three-month results. Each bar shows net income nested inside revenue, since profit is the slice of revenue left after all costs; the taller the green portion relative to the blue, the more of each sales dollar reached the bottom line. A bar below zero is a quarterly loss.

For a long-term view, compare each quarter with the same quarter a year earlier (year-over-year), not with the previous quarter — sequential change is mostly seasonality (for many businesses the holiday quarter is always the biggest). Then watch the trend across several years: is year-over-year revenue growth accelerating or fading; is net income growing at least as fast as revenue (expanding vs compressing margins)? One quarter is noise — the multi-quarter trend is the signal.

McKesson Corporation Share Price vs Book Value

McKesson Corporation (MCK) share price vs book value per share — FY2017 – FY2026

Understanding Share Price vs Book Value

Share Price is what the market pays per share of McKesson Corporation. Book Value per Share (BVPS) is the company's net equity divided by diluted shares — the accounting floor if the company were liquidated today. When price tracks close to book value the market sees the company as a steady asset; when price runs far above book the market is paying up for expected future earnings. For banks, book value is the primary valuation anchor; for most other companies it's one signal among many.

Unlock Valuation Analysis

Get fair value estimates from multiple valuation models and see whether a stock is undervalued or overvalued.

  • Multi-model fair value estimates (P/E, DCF, EPS Growth)
  • Undervalued/overvalued assessment with upside potential
  • Compare fair values across methodologies

McKesson Corporation Free Cash Flow

5-year trend — cash generated after reinvestment

FY2022 – FY2026

McKesson Corporation's free cash flow of $5.72B in FY2026 represents a 1.4% FCF margin, leaving limited capacity for shareholder returns after reinvestment.

Understanding Free Cash Flow

Free Cash Flow (FCF) is McKesson Corporation's operating cash flow minus capital expenditure — the cash left over after maintaining and growing the business. Unlike net profit, FCF strips out non-cash items (depreciation, stock-based compensation) and includes actual cash spent on assets. Positive FCF means the company can pay dividends, buy back shares, reduce debt, or make acquisitions without raising capital. Consistently negative FCF signals the company is burning cash and may need external funding.

McKesson Corporation Financial Ratios

Balance sheet strength and debt servicing capacity

FY2022 – FY2026

Debt-to-Equity

N/A

Negative equity

Current Ratio

0.85

▼ from 0.90

Interest Coverage

26.1x

▲ from 17.1x

McKesson Corporation has negative shareholder equity (equity deficit), a current ratio of 0.85, interest coverage of 26.1x in FY2026, which suggest adequate financial health with manageable leverage.

Understanding Financial Health

Debt-to-Equity (D/E) measures how much debt the company carries relative to shareholder equity — lower means less leverage risk. Current Ratio divides current assets by current liabilities — above 1.0 means the company can cover short-term obligations. Interest Coverage is operating income divided by interest expense — higher means the company earns well above its debt payments. Together these three metrics reveal whether a company can weather downturns without financial distress.

McKesson Corporation Shares Outstanding

Diluted share count per fiscal year — labels show year-over-year change

FY2022 – FY2026

McKesson Corporation's diluted shares decreased 3.1% YoY in FY2026, indicating shareholder-friendly buybacks.

Understanding Shares Outstanding

Diluted shares outstanding counts every share of McKesson Corporation that could exist if all stock options, RSUs, and convertibles were exercised. A shrinking count signals buybacks (returning cash to shareholders by reducing the denominator of EPS). A growing count signals dilution — usually from stock-based compensation, secondary offerings, or stock-funded acquisitions. Routine 1–2% growth is typical at large-cap tech companies that pay employees in equity; sustained growth above 5% warrants a look at the cause.

Unlock Full Analysis

Unlock 10-year interactive charts, all 5 valuation models, and full screener access.

Related Stocks